Dendritic cells (DCs) are responsible for the initiation of immune responses. Our study demonstrates a new pathway for generating a large quantity of stimulatory monocyte-derived DCs (Mo-DCs) from human monocytes using anti-4-1BB ligand (4-1BBL) mAb to trigger reverse signaling. The anti-4-1BBL-driven Mo-DCs (DCs a-4-1BBL ) not only express higher levels of CD86, CD83 and HLA-DR, when compared with the Mo-DCs matured by tumor necrosis factor a, but also exhibit a unique phenotype that expresses lower levels of PD-L1. High levels of GM-CSF, M-CSF and Flt3 ligand (FL) were found in the anti-4-1BBL-differentiation culture. Neutralizing M-CSF, GM-CSF and FL inhibited Mo-DC proliferation stimulated by anti-4-1BBL mAb, suggesting that M-CSF, GM-CSF and FL are involved in cell proliferation stimulated by anti-4-1BBL. Further analysis of the DCs a-4-1BBL showed increased secretion of T h 1-type cytokines IL-12 and IFN-g and decreased secretion of IL-10. DCs a-4-1BBL induced much stronger proliferative responses in the mixed lymphocyte reaction assay when compared with DCs derived by GM-CSF. Moreover, DCs a-4-1BBL preferentially induced T h 1 responses. We have further demonstrated that anti-4-1BBL antibody stimulated nuclear translocation of NF-kB from the cytoplasm in monocytes, suggesting that reverse signaling by 4-1BBL is likely responsible for mediating DC differentiation. Collectively, we have found that reverse signaling of 4-1BBL promotes the differentiation of potent T h 1-inducing DCs from human monocytes.
Introduction
Dendritic cells (DCs) are very potent antigen-presenting cells (APCs) that play critical roles in the initiation of T cellmediated immune responses as well as maintaining tolerance (1, 2) . Over the past few years, there has been a surge of interest in immunotherapy by enhancing T cell responses via the administration of DCs that have been 'pulsed' with tumor-specific antigens to cancer patients. It has been reported that DCs can be generated through ex vivo expansion from precursors, such as monocytes and CD34
+ stem cells in the presence of cytokines such as GM-CSF and IL-4 (3-7). Further maturation with increased expression of CD83 can be achieved when cultured in the presence of tumor necrosis factor (TNF) a (8, 9) . Cytokines, such as IL-1b, CD40 ligand and IFN-c, might be used to enhance the DC capability to induce T cell responses (10) (11) (12) (13) (14) . Because DCs can either activate or induce tolerance in T cells, it is critical to establish pathways that promote the generation of DCs that promote T h 1 responses.
T cell activation requires secondary signals produced by the ligation of co-stimulatory molecules on T cells and their ligands on DCs. Signal is believed to initiate from ligand which triggers signaling through their receptors expressed on the surface of their target cells. Interestingly, recent studies demonstrated that signaling can be bi-directional; many ligands can serve as counter-receptors and stimulate DCs through reverse signals (15) . Bi-directional transduction of signals exists for the 4-1BB, OX40, CD27, CD95 and CD30 receptor/ligand system as well (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . The functional significance of reverse signaling on APCs, particularly DCs, remains an open question.
4-1BB is expressed on the activated CD4
+ and CD8 + T cells. The 4-1BB ligand (4-1BBL) is expressed on many types of cells, including IFN-activated macrophages, CD40 ligand-activated B cells, DCs and monocytes. Co-stimulation by 4-1BBL appears to regulate the later phases of cytotoxic and pro-inflammatory T cell activation, enhanced proliferation, survival, effector function and the induction of T cell memory (26) (27) (28) . Previous studies showed that human monocytes cultured with immobilized 4-1BB-Fc protein or anti-4-1BBL mAb induce proliferation and cytokine production (15) (16) (17) (18) (19) , suggesting that reverse signaling of 4-1BBL is functional in these cells. Whether 4-1BBL reverse signaling is involved in the development of human DCs is unclear. In this study, we demonstrated that large quantities of human DCs were generated from monocytes via 4-1BBL reverse signaling. We further showed that the monocyte-derived DCs (Mo-DCs) generated by 4-1BBL reverse signaling and IL-4 had mature phenotypes, secreted higher amounts of T h 1-driving cytokines and expressed lower levels of PD-L1. Moreover, the anti-4-1BBL-driven Mo-DCs (DCs a-4-1BBL ) were more potent in stimulating T cell proliferation and promoting T h 1 responses.
Materials and methods

Reagents
M-CSF, GM-CSF, IL-4, neutralizing goat anti-human GM-CSF, goat anti-human M-CSF, goat anti-human Flt3 ligand (FL) polyclonal antibodies and normal goat IgG were purchased from R&D Systems (Minneapolis, MN, USA). Anti-CD80-PE, anti-CD86-PE, anti-CD83-PE, anti-HLA-DR-PE, biotinlyted antihuman CD3, CD8, CD14, CD16, CD19, CD56, CD45RO mAbs, avidin beads and magnetic-activated cell sorting (MACS) columns were obtained from Immunotech (Marseille, France). Anti-human 4-1BBL-PE (C65-485) was purchased from BD Biosciences (San Jose, CA, USA). Anti-4-1BBL mAb 1F1 was prepared in our laboratory (19) . FITC-dextran (MW 40 000) was obtained from Sigma (St. Louis, MO, USA).
Isolation of human peripheral monocytes and naive CD4 + T cells
PBMCs were isolated from healthy human peripheral blood (Suzhou Central Blood Bank, China) by Ficoll-Hypaque (Shanghai Second Chemistry Factory, China) gradient centrifugation. PBMCs were re-suspended in RPMI 1640 containing 10% FCS and put on 6-well plates and then incubated in 37°C, 5% CO 2 , for 2 h. After removing the suspended cells, the adhesive cells were collected with cold PBS washing. Monocytes were sorted from these adhesive cells by using MACS columns with microbead-coated murine anti-human CD3, CD16, CD19 and CD56 mAbs. T cells were isolated from PBMCs by depleting the cells expressing CD14, CD8, CD16, CD19, CD45RO and CD56 using MACS columns. The purity of the isolated monocytes (CD14 + cells) and CD4
+ T cells was >95%.
Generation of Mo-DCs
DCs Cytokine secretion of Mo-DCs further stimulated by anti-4-1BBL mAb 1F1 DCs IMAT were generated through ex vivo expansion from monocytes with GM-CSF (25 ng ml À1 ) plus IL-4 (1000 U ml À1 ), collected and washed at day 5. Then these DCs IMAT (2 3 10 6 ml À1 ) were treated with immobilized mAb 1F1 or irrelevant mouse IgG1 for 3 days. The supernatants were collected to measure the cytokine production.
Allogeneic mixed lymphocyte reaction (MLR)
DCs a-4-1BBL , DCs MAT or DCs IMAT were treated with mitomycin C (50 mg ml 
Culture of T h cells and intracellular cytokine staining
DCs a-4-1BBL or DCs MAT were co-cultured with allogeneic naive CD4
+ T cells at a ratio of 1:5 in 24-well plates. At day 7 of co-culture, the expanded T cells were re-stimulated with phorbol myristate acetate (50 ng ml À1 ; Sigma) and ionomycin (1 lg ml À1 ; Sigma) for 6 h in the presence of Brefeldin A (10 lg ml À1 ; Sigma) during the last 5 h of stimulation. After formaldehyde fixation and subsequent saponin permeabilization, cells were stained with FITCconjugated anti-CD4 and PE-conjugated anti-IFN-c or anti-IL-4 antibodies (e-Bioscience). Cells were analyzed on FACScan flow cytometer (Altra, Beckman Coulter, Fullerton, CA, USA).
Comparison of the endocytosis ability during the induction of DCs a-4-1BBL and DCs MAT Cells were harvested at the different time points during the induction of DCs a-4-1BBL and DCs MAT . The ability of Mo-DCs to capture antigen was measured by the cellular uptake of FITC-dextran. Mo-DCs were treated with FITC-dextran (1 mg ml À1 ) for 30 min at either 37 or 4°C (negative control) in RPMI 1640 containing 10% FBS. These cultures were washed four times in cold PBS and then analyzed by flow cytometry.
Flow cytometry analysis
Harvested cells were washed in PBS supplemented with 5% FBS, and then 1 3 10 7 ml À1 cells were stained with various antibody conjugates at 10 lg ml À1 in PBS with 3% FBS for 30 min at 4°C. Fluorescence was measured using a FACScan flow cytometer.
ELISA
ELISA kits were purchased from R&D Systems and ELISA was performed according to the manufacturer's instructions. Cytokine concentrations were determined in triplicate and expressed as mean 6 standard deviation.
NF-jB translocation assay
Monocytes were treated with mAb 1F1 or irrelevant mouse IgG1 for different lengths of time as indicated in each figure. Cells were fixed for 30 min in 4% PFA. Cells were washed with chilled PBS, permeabilized with Triton X-100, washed again and incubated with polyclonal rabbit anti-NF-jB p65 antibody (1:200 dilution, Santa Cruz) for 1 h at room temperature. After washing, cy3-conjugated goat anti-rabbit antibody was added and incubated for 1 h at room temperature. 4#,6-Diamidino-2-phenylindole was added and incubated for 5 min to visualize cell nuclei. Washed cells were analyzed using a laser-scanning microscope (Zeiss, Jena, Germany).
Results
Monocytes could differentiate into Mo-DCs in culture with anti-4-1BBL mAb 1F1 plus IL-4
Monocytes were cultured in 24-well plates (or in 96-well plate) pre-coated with mAb 1F1 in the presence of IL-4. We found that monocytes in culture with mAb 1F1 plus IL-4 developed to mature DCs (Fig. 1A) . The 4-1BBL molecule was consistently expressed on the cell surface during the formation and maturation of DCs (Fig. 1B) . As measured by Fig. 1C) . Since proliferation of Mo-DCs depends on a series of cytokines, we suspected that mAb 1F1-induced 4-1BBL reverse signaling stimulated some autocrine factors. Indeed, in the supernatants of Mo-DCs generated by mAb 1F1 and IL-4, we detected higher amounts of M-CSF, FL and GM-CSF ( Fig. 2A) . In addition, as measured by [ 3 H]TdR incorporation, neutralizing goat anti-M-CSF, goat anti-FL and goat anti-GM-CSF polyclonal antibodies, respectively, partially inhibited the proliferation of Mo-DCs (Fig. 2B) . A complete inhibition of Mo-DC proliferation was achieved by neutralizing M-CSF, FL and GM-CSF all together (Fig. 2B) . Also, in the DC cultures of neutralizing M-CSF, FL or GM-CSF, smaller colonies or cell aggregates were observed, and in the DC cultures of neutralizing M-CSF, FL and GM-CSF all together few of them were observed (Fig. 2B) . Therefore, these cytokines were required for DC differentiation in these cultures.
The phenotypes of DCs a-4-1BBL , DCs IMAT and DCs MAT Although both our method and the classical method can induce monocytes to differentiate into a number of Mo-DCs, their cell surface phenotypes are different. Compared with GM-CSF/IL-4-derived DCs (DCs IMAT ), the DCs a-4-1BBL expressed lower levels of CD14 and higher levels of CD86, CD83 and HLA-DR, which were similar to the TNF-a-matured Mo-DCs (DCs MAT ). In contrast, CD80 expression was modestly lower on DCs a-4-1BBL when compared with that on DCs IMAT and DCs MAT . Interestingly, the level of PD-L1, a molecule that is involved in T cell tolerance and exhaustion, was low on DCs a-4-1BBL but was quite high on DCs MAT (Fig. 3) . Because PD-L1 can inhibit the activation of T cells, DCs a-4-1BBL are likely more potent than DCs MAT in inducing T cell responses.
The dynamics of the endocytosis ability of Mo-DCs
The efficiency of Mo-DC endocytosis was assessed using FITC-conjugated dextran. We found that the ability of MoDCs cultured with mAb 1F1 plus IL-4 to endocytosis decreased after 5 days of DC development (Fig. 4) , suggesting that 4-1BBL signaling resulted in DC maturation.
The cytokine profiles during the differentiation of DCs a-4-1BBL
In order to evaluate whether functional changes of DCs a-4-1BBL were mediated by soluble autocrine factors, human monocytes were cultured for 7 days with different stimuli and their supernatants were subsequently harvested. In the supernatants of cultures with mAb 1F1 plus IL-4, compared with the control group, we detected higher levels of IL-12, IL-6, TNF-a and IFN-c and lower levels of IL-10 ( Fig. 5A) . Because IL-6, TNF-a and IFN-c can promote DC maturation, an increase of these cytokines might explain why the DCs a-4-1BBL had mature phenotypes. The decrease of IL-10, a negative regulatory cytokine on DCs, might also contribute positively to DC maturation.
4-1BBL stimulation induces cytokine production from the classically generated immature DCs
Because anti-4-1BBL antibodies induced inflammatory cytokine production during differentiation of DCs a-4-1BBL from monocytes, we would like to determine whether this stimulation can also trigger cytokine production by immature DCs derived using the GM-CSF and IL-4. DCs generated from monocytes in a culture of GM-CSF and IL-4 for 5 days were cultured on 24-well plastic plates coated with mAb 1F1 for another 3 days. In the supernatants from this culture, we detected increased secretion of GM-CSF, M-CSF, FL, IL-6, TNF-a, IL-12 and IFN-c and decreased secretion of IL-10, which benefits DC proliferation or function regulation (Fig. 5B) . Therefore, anti-4-1BBL mAb 1F1 can both induce monocyte differentiation to DCs and activate DCs. To further examine the function of DCs a-4-1BBL , the primary allogeneic MLR assay was performed. Our data (Fig. 6A) showed that DCs a-4-1BBL were the most potent for stimulating T cells to proliferate in MLR assay. Both DCs a-4-1BBL and DCs MAT could activate T cells effectively. However, DCs a-4-1BBL preferentially induced T h 1 responses. Our data (Fig. 6B) showed that DCs a-4-1BBL induced CD4
+ T cells to produce higher levels of IFN-c and lower levels of IL-4 compared with the T cells stimulated by DCs MAT .
NF-jB is involved in 4-1BB/4-1BBL reverse signaling
We have already shown that mAb 1F1 could induce proliferation and differentiation of monocytes. We suspect that the biological effects of anti-4-1BBL antibody are attributable to ) plus goat anti-human GM-CSF polyclonal antibody (2 lg ml À1 ) (5) and mAb 1F1 plus IL-4 plus normal goat IgG (6 lg ml À1 ) (6), respectively. (*P < 0.05 by Student's t test.) its ability to induce 4-1BBL reverse signaling in human monocytes. We therefore decided to examine whether anti-4-1BBL antibody could activate 4-1BBL reverse signaling. Nuclear translocation of NF-jB in monocytes was then determined with specific anti-NF-jB p65 antibody by indirect immunofluorescence and confocal laser-scanning microscopy. Prior to 4-1BBL stimulation, NF-jB was present in the cytosol. After 30 min of 4-1BBL stimulation, some of the NF-jB protein was found localized in the nucleus of monocytes (Fig. 7A, middle part) . After 1 h of anti-4-1BBL stimulation, the majority of NF-jB protein was found in the cell nucleus (Fig. 7A, right part) . These data suggest that anti-4-1BBL treatment triggers a signaling event that leads to NF-jB activation.
Discussion
DCs are the most potent APCs, required for the initiation of antigen-specific immune response. Evidence is accumulating that while DCs induce T cell response, T cells can also affect the DC function via reverse signaling (29, 30) . A recent study confirms that 4-1BB-4-1BBL interaction generates signals that can be transduced bi-directionally in both the ligand-and receptor-expressing cells (15) (16) (17) (18) (19) . Therefore, we hypothesized that 4-1BBL reverse signaling played an important role in regulating DC development or function. In this study, we demonstrated that 4-1BBL reverse signaling induces DC development from human monocytes.
Anti-4-1BBL elicited many responses in human monocytes. Our data showed that monocytes cultured with mAb 1F1 plus IL-4 proliferate with vigor and generated large numbers of DCs. Neutralizing anti-M-CSF antibody and anti-GM-CSF antibody could inhibit DC proliferation to a certain extent. FL is also an important growth factor for DCs (31) (32) (33) (34) (35) . Neutralizing goat anti-FL polyclonal antibody could significantly inhibit DC proliferation. Our results established that FL also plays a pivotal role in DC proliferation stimulated by 4-1BBL reverse signaling. Although neutralizing M-CSF, FL or GM-CSF alone only partly reduced DC proliferation, neutralizing them all together inhibited proliferation completely. Therefore, DC proliferation mediated by 4-1BBL reverse signaling may mainly depend on a combination of M-CSF, FL and GM-CSF.
We found that monocytes in culture with mAb 1F1 plus IL-4 for 7 days exhibited unique DC phenotypes. Flow cytometry analysis revealed that when compared with the DCs IMAT , the DCs a-4-1BBL exhibited mature phenotypes with higher levels of CD86, CD83 and HLA-DR and lower levels of CD14. These phenotypes are similar to the Mo-DCs matured by TNF-a. Consistent with these results, 5 days after the Mo-DCs were cultured, we observed a significant decrease of endocytosis in Mo-DCs. Interestingly, the DCs a-4-1BBL expressed much lower levels of PD-L1 compared with DCs matured by TNF-a, which expressed very high levels of PD-L1. Because PD-L1 is involved in T cell tolerance and exhaustion (36, 37) , DCs a-4-1BBL should, therefore, be more potent in sustaining a cell-mediated immune response. Furthermore, in the supernatants of DCs a-4-1BBL , we detected higher levels of IFN-c, IL-6, TNF-a and IL-12 and lower levels of IL-10. These soluble autocrine factors are known to act as important co-stimulatory cytokines for T cell activation (38) (39) (40) (41) (42) (43) (44) (45) and, importantly, higher levels of IFN-c and IL-12, coupled with lower levels of IL-10, are considered to be critical factors in inducing a T h 1-type immune response. On the other hand, because IFN-c and TNF-a are responsible for DC maturation (7, 8, 12, 13) , the autocrine effects of an increase in these cytokines on DCs may help them acquire mature phenotypes. Some studies confirmed that IL-6 combined with TNF-a and IL-1b could stimulate DC maturation (44, 45) . Therefore, IL-6 combined with other cytokines enhanced by 4-1BBL reverse signaling may be involved in Mo-DC maturation. IL-10 was reported to downregulate expression of HLA-DR and CD86 on DCs, suppressing the capability of DCs to stimulate allo-reactive T cells (46, 47) and inhibiting differentiation of Mo-DCs with GM-CSF and IL-4 (48) . Therefore, the reduction of IL-10 might contribute to Mo-DC differentiation and maturation in our culture. In brief, up/down-regulation of these cytokines may partly explain the mechanism that regulates the maturation of Mo-DCs by 4-1BBL reverse signaling.
The functional activities of Mo-DCs were determined by the primary allogeneic MLR assay. We found that, when compared with DCs IMAT , DCs a-4-1BBL were better able to activate T cells in MLRs. Particularly, we found that the capability of DCs a-4-1BBL to activate T cells was stronger than in DCs MAT . Furthermore, we showed that DCs a-4-1BBL preferentially induced T h 1 responses. These data were consistent with our findings that anti-4-1BBL promoted Mo-DC T h 1 cytokine production. We suspected that the DCs a-4-1BBL might secrete higher levels of cytokines for T cell activation. We found that 4-1BBL reverse signaling could down-regulate the expression of PD-L1, while TNF-a up-regulated its expression. PD-L1 is an important negative co-stimulatory molecule for T cell activation. PD-L1 was reported to reduce T cell priming, prevent infiltration into tissues by effector T cells and serve as a mechanism for immune evasion by some tumors. Blocking PD-L1 enhances myeloid DC-mediated T cell activation and reduces the growth of transplanted human ovarian carcinoma in non-obese diabetic SCID mice adoptively transferred with autologous human TAA-specific T cells (49, 50) . Thus, down-regulation of PD-L1 may be an important factor for 4-1BBL reverse signaling to enhance the ability to activate T cells. Therefore, promoting DC maturation, promoting T h 1-type cytokine production and inhibiting DC PD-L1 expression by 4-1BBL reverse signaling might help to establish effective tumor immunity in cancer immune therapy.
To further establish whether the effect of 1F1 antibody is due to its ability to trigger signaling in 4-1BBL-expressing cells, we examined its effect on NF-jB. We found that NF-jB translocation was stimulated by anti-4-1BBL stimulation, which suggests a link between the 4-1BBL and NF-jB pathways. These data provide direct evidence of the presence of 4-1BBL reverse signaling.
Taken together, our findings suggest a new way for generating Mo-DCs. According to our findings, we hypothesize that when T cells are activated by DCs, they express 4-1BB. Then, 4-1BBL reverse signaling triggered by 4-1BB contributes to the differentiation of functional mature DCs. Whether this is the case in vivo that needs to be tested further. However, we also suggest that 4-1BBL reverse signaling-driven Mo-DC generation in vitro may be valuable in a DC-based immune therapy against cancers. 
